Cardiac allograft vasculopathy: do adipocytes bridge alloimmune and metabolic risk factors?

Jennifer R Wehner1, William M Baldwin

  • 1Department of Immunology NB30, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, Ohio, USA.

Insights

Cardiac allograft vasculopathy (CAV) is linked to inflammation. Perivascular fat imbalances in cytokines may worsen immune injury in transplanted heart arteries, contributing to graft failure.

Area of Science:

  • Immunology
  • Cardiology
  • Metabolic Science

Background:

  • Cardiac allograft vasculopathy (CAV) is a primary cause of chronic graft failure after heart transplantation.
  • CAV is characterized by intimal expansion, inflammation, and fibrosis in coronary arteries.

Purpose of the Study:

  • To review recent publications linking metabolic and immunologic risk factors for CAV.
  • To propose that periarterial adipocytes contribute to immune injury in coronary arteries.

Main Methods:

  • Review of clinical and experimental evidence.
  • Analysis of cytokine secretion by perivascular adipose tissue.
  • Examination of antibody associations with CAV.

Main Results:

  • Alloantibodies and autoantibodies are associated with CAV.
  • Perivascular adipose tissue releases proinflammatory cytokines (IL-6, IL-8, MCP-1) and less anti-inflammatory adiponectin.
  • Adiponectin influences vascular endothelium and reduces neointimal formation.

Conclusions:

  • Imbalances in perivascular fat cytokines are implicated in atherosclerosis and restenosis.
  • This cytokine imbalance may exacerbate immune responses in transplanted heart coronary arteries.
Abstract